Cargando…
Combined Action of Anti-MUC1 Monoclonal Antibody and Pyrazole-Platinum(II) Complexes Reveals Higher Effectiveness towards Apoptotic Response in Comparison with Monotherapy in AGS Gastric Cancer Cells
MUC1 mucin is a transmembrane glycoprotein aberrantly overexpressed and underglycosylated in most epithelium origin cancers. Combining chemotherapeutics with monoclonal antibodies toward cancer-related antigens is one of the new strategies in cancer therapies. In this study, we assessed the effectiv...
Autores principales: | Supruniuk, Katarzyna, Czarnomysy, Robert, Muszyńska, Anna, Radziejewska, Iwona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309157/ https://www.ncbi.nlm.nih.gov/pubmed/34206951 http://dx.doi.org/10.3390/pharmaceutics13070968 |
Ejemplares similares
-
Anti-cancer effects of pyrazole-platinum(II) complexes combined with anti-MUC1 monoclonal antibody versus monotherapy in DLD-1 and HT-29 colon cancer cells
por: Supruniuk, Katarzyna, et al.
Publicado: (2022) -
Tiliroside Combined with Anti-MUC1 Monoclonal Antibody as Promising Anti-Cancer Strategy in AGS Cancer Cells
por: Radziejewska, Iwona, et al.
Publicado: (2023) -
Anti-Cancer Potential of Afzelin towards AGS Gastric Cancer Cells
por: Radziejewska, Iwona, et al.
Publicado: (2021) -
MUC1 is an oncoprotein with a significant role in apoptosis (Review)
por: Supruniuk, Katarzyna, et al.
Publicado: (2021) -
The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells
por: Gornowicz, Agnieszka, et al.
Publicado: (2015)